ABOUT

Mohammad Al-Mahdi Al-Karagholi is a medical doctor with a research interest in therapeutic novelties in migraine. In the last three years, he has been studying the role of ATP sensitive potassium channels in migraine pathophysiology in migraine with and without aura patients. He has also been involved in clinical trials investigating migraine prevention with monoclonal antibodies.